Drugs for pre-osteoporosis: prevention or disease mongering?
Alonso-Coello
Pablo
P
Iberoamerican Cochrane Center, Department of Clinical Epidemiology and Public Health, Hospital de Sant Pau, Universidad Autónoma de Barcelona, 08041, Barcelona, Spain. palonso@santpau.es
García-Franco
Alberto López
AL
Guyatt
Gordon
G
Moynihan
Ray
R
D050071:Bone Density Conservation Agents / Q000009:adverse effects / Q000627:therapeutic use*; D016265:Conflict of Interest; D005260:Female; D006801:Humans; D008389:Marketing of Health Services; D015201:Meta-Analysis as Topic; D010024:Osteoporosis / Q000188:drug therapy*; D018570:Risk Assessment; D012307:Risk Factors
D050071:Bone Density Conservation Agents